How RDC 873/2024 Transforms Healthcare and Opens New Markets for Online Medicine Introduction to the Evolution of Prescription Regulation in Brazil The Evolution of Prescription Regulation in Brazil marks a pivotal moment with the introduction of RDC 873/2024, a regulation by the National Health Surveillance Agency (ANVISA). This new regulation introduces the Sistema Nacional de […]
Tag: pharmaceutical compliance
International Integration Guide: Brazil ANVISA PIC/S Membership
Understanding Brazil’s Global Partnerships in Pharmaceutical Compliance Introduction to ANVISA International Integration Guide The ANVISA International Integration Guide explores Brazil ANVISA PIC/S Membership commitment to aligning its pharmaceutical regulations with global standards. Through strategic alliances, including its recent membership in the Pharmaceutical Inspection Co-operation Scheme (PIC/S), the Brazilian Health Regulatory Agency (ANVISA) is enhancing its […]
Pharmaceutical Registration in Brazil
A Complete Guide Description: This comprehensive guide outlines the process for pharmaceutical product registration in Brazil, detailing the specific requirements mandated by ANVISA (Brazilian Health Regulatory Agency). Successfully navigating this process is essential for companies seeking to enter Brazil’s highly regulated healthcare and pharmaceutical markets. We’ll cover crucial steps like petition preparation, protocol registration, and […]
CBD Regulatory Compliance Brazil
Navigating the Path to Market Entry in 2024 Introduction to CBD Regulatory Compliance Brazil The expanding CBD sector in Brazil presents a promising market, with an estimated value of $1.6 billion by 2030. Success in this dynamic industry, however, depends on navigating CBD Regulatory Compliance Brazil. Driven by evolving regulations, such as ANVISA’s RDC 327 […]